You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

molecular subtype

Showing 26 - 50 of 5,769
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent DLBCL Activated B-Cell Type, Recurrent DLBCL Germinal Center B-Cell Type, Recurrent High Grade B-Cell Lymphoma With

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • +8 more
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 8, 2023

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

MiT Family Translocation Renal Cell Carcinomas (IMCOR)

Not yet recruiting
  • Renal Carcinoma
  • Data collection
  • Bordeaux, France
  • +3 more
Jul 8, 2022

Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

Recruiting
  • Astrocytoma, Grade IV
  • +7 more
    • Valencia, Spain
      Biomedical Data Science Lab. Universitat Politècnica de València
    May 11, 2022

    Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

    Recruiting
    • Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • "3+7"
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 29, 2023

    Breast Cancer Trial in Istanbul (Carbon Black Tattoo)

    Recruiting
    • Breast Cancer
    • Carbon Black Tattoo
    • Istanbul, Turkey
      Gaziosmanpasa Training and Research Hospital
    Feb 17, 2023

    Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

    Not yet recruiting
    • Endometrial Carcinoma
    • Tumor Molecular Features Screening Model
    • open surgery
    • laparoscopic surgery
    • (no location specified)
    Jun 7, 2023

    AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • chidamide and azacitidine
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Sep 27, 2023

    68Ga-Pentixafor PET/CT for Subtyping Diagnosis of Primary

    Completed
    • Primary Aldosteronism
    • 68Ga-Pentixafor PET/CT imaging
    • Chongqing, Chongqing, China
      The First Affilated Hospital of Chongqing Medical University
    Jul 13, 2022

    New Treatment Strategies in Eastern European Region and in

    Recruiting
    • HIV-1-infection
      • Cologne, Germany
      • +3 more
      Nov 10, 2023

      Endometrial Cancer Trial in Vancouver (Treatment de-escalation)

      Recruiting
      • Endometrial Cancer
      • Treatment de-escalation
      • Vancouver, British Columbia, Canada
        BC Cancer - Vancouver Centre
      Mar 1, 2022

      Low-grade Glioma Trial in San Francisco (ReMind iPad app, Healthy SMS texting, In-person cognitive rehabilitation)

      Recruiting
      • Low-grade Glioma
      • ReMind iPad app
      • +3 more
      • San Francisco, California
        University of California, San Francisco
      Nov 16, 2022

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
      • Best-Available Therapy(BAT) Regimen
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Oct 10, 2023

      ADjuvant chemotherAPy After Curative Intent resecTion of

      Recruiting
      • Ampullary Adenocarcinoma
      • Brescia, BS, Italy
        Fondazione Poliambulanza
      Oct 3, 2023

      Chronic Lymphocytic Leukemia (CLL) Trial

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
        • (no location specified)
        Apr 5, 2022

        Using Comprehensive Genomic Data on Next Treatment Decision

        Active, not recruiting
        • Metastatic Breast Cancer
        • blood sample collection and collection of tumor tissue block
        • Barcelona, Please Select, Spain
          Translational Genomics and Targeted Therapeutics in Solid Tumour
        Oct 24, 2022

        Collecting Ducts Carcinoma: in Depth Exploration and

        Recruiting
        • Collecting Duct Carcinoma
          • Milano, Italy
            Fondazione IRCCS Istituto Nazionale Tumori
          May 9, 2022

          Small Renal Mass, Kidney Tumor Trial in Chapel Hill (Small Renal Mass Biopsy, No Small Renal Mass Biopsy)

          Recruiting
          • Small Renal Mass
          • Kidney Tumor
          • Small Renal Mass Biopsy
          • No Small Renal Mass Biopsy
          • Chapel Hill, North Carolina
            UNC Lineberger Comprehensive Cancer Center
          Mar 22, 2022

          Blastocystis Isolates From Human by Restriction Fragment Length

          Not yet recruiting
          • Blastocystis Infections
          • RFLP analysis of SSU rRNA
          • (no location specified)
          Oct 13, 2022

          Colorectal Cancer Peritoneal Metastases

          Not yet recruiting
          • Colorectal Cancer Metastatic
          • Retrospective tissue sample analysis
          • (no location specified)
          Aug 22, 2022

          Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

          Recruiting
          • Invasive Breast Carcinoma
          • +11 more
          • Conroe, Texas
          • +4 more
          May 3, 2022

          (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of

          Recruiting
          • Colorectal Neoplasms
            • Maastricht, Limburg, Netherlands
              Maastricht UMC+
            Jan 10, 2023

            Network - Breast : Genomic Profiling of Breast Cancer

            Recruiting
            • Breast Neoplasms
              • Halmstad, Sweden
              • +8 more
              Sep 9, 2021

              Analysis of miRNA Expression in Endometrial Cancer

              Recruiting
              • Endometrial Cancer
                • Bologna, Bo, Italy
                  IRCCS- Azienda Ospedaliera-Universitaria di Bologna
                Jul 19, 2022

                Triple-negative Breast Cancer Trial in Shanghai (choline, anti-PD-1 antibody and chemo, Sodium Cromoglicate)

                Recruiting
                • Triple-negative Breast Cancer
                • Shanghai, China
                  Fudan University Shanghai Cancer Center
                Sep 29, 2022